Improved understanding of the pattern of white matter changes in early and prodromal Alzheimer's disease (AD) states such as mild cognitive impairment (MCI) is necessary to support earlier preclinical detection of AD, and debate remains whether white matter changes in MCI are secondary to gray matter changes. We applied neuropsychologically based MCI criteria to a sample of normally aging older adults; 32 participants met criteria for MCI and 81 participants were classified as normal control (NC) subjects. Whole-head high resolution T1 and diffusion tensor imaging scans were completed. Tract-Based Spatial Statistics was applied and a priori selected regions of interest were extracted. Hippocampal volume and cortical thickness averaged across regions with known vulnerability to AD were derived. Controlling for cortical thickness, the MCI group showed decreased average fractional anisotropy (FA) and decreased FA in parietal white matter and in white matter underlying the entorhinal and posterior cingulate cortices relative to the NC group. Statistically controlling for cortical thickness, medial temporal FA was related to memory and parietal FA was related to executive functioning. These results provide further support for the potential role of white matter integrity as an early biomarker for individuals at risk for AD and highlight that changes in white matter may be independent of gray matter changes. (JINS, 2013, 19, 925-937) 
INTRODUCTION
The development of pharmacological treatments that may slow or halt the Alzheimer's disease (AD) process has served as an impetus for the early detection of dementia and the accurate identification of prodromal dementia states, including mild cognitive impairment (MCI). Recent work has focused on the identification of biomarkers for early detection, and structural magnetic resonance imaging (MRI) has proven to be a reliable biomarker for predicting future decline (Jack et al., 2010) . Hippocampal volume and other indices of medial temporal lobe (MTL) atrophy are championed as promising MR biomarkers (Craig-Schapiro, Fagan, & Holtzman, 2009 ), but hippocampal atrophy may have multiple etiologies (Dhikav & Anand, 2012) and early gray matter (GM) changes can be detected beyond the MTL in prodromalthinning in ''AD-signature'' areas among cognitively normal individuals (Dickerson et al., 2011) .
Despite strong neuropathological evidence of white matter (WM) changes in AD (Brun & Englund, 1986) , the role of WM in the development of AD and its utility as a structural MR biomarker has been largely overlooked. With the advent of diffusion tensor imaging (DTI), numerous studies have demonstrated changes in regional WM integrity in AD Stricker et al., 2009) , and decreases in WM integrity are also reliably found before the diagnosis of clinical dementia (Delano-Wood et al., 2010; Fellgiebel et al., 2005; Parente et al., 2008; Wang et al., 2009) . WM changes may complement GM changes, explaining unique variance in the disease process. For example, the combination of DTI and cortical thickness measures has higher sensitivity and specificity to differentiate amnestic MCI (aMCI) from healthy control participants than either measure in isolation , highlighting the need to examine both imaging modalities in MCI. DTI studies of MCI have shown changes in WM integrity, most reliably within medial temporal and parietal regions (Bosch et al., 2012; Huang et al., 2012; Huang & Auchus, 2007; Jacobs, Van Boxtel, Jolles, Verhey, & Uylings, 2012; Medina et al., 2006; Rose et al., 2006; Scola et al., 2010; Zhuang et al., 2010) believed to underlie episodic memory (Buckner, Andrews-Hanna, & Schacter, 2008; Walhovd et al., 2009) .
The relative importance of GM versus WM changes in MCI remains unclear. Although GM changes have traditionally been viewed as most important to the AD pathological process and clinical expression, recent research has challenged this assumption and there is increasing evidence of the potential utility of WM integrity as an early biomarker, with longitudinal evidence that it uniquely predicts cognitive decline relative to cerebrospinal fluid (CSF) biomarkers and GM volume (Scola et al., 2010; Selnes et al., 2013; Zhuang et al., 2012) . In addition, there is evidence that changes in WM integrity may have unique effects that independently or synergistically contribute to effects of GM atrophy; for example, we have previously shown evidence that WM changes persist when statistically controlling for GM measures in AD Stricker et al., 2009 ). To our knowledge, only three studies have tested whether WM changes persist when controlling for GM in MCI (Bosch et al., 2012; Delano-Wood et al., 2012; Selnes et al., 2013) , with varying methods and results. Bosch and colleagues controlled for total GM volume, which may be insensitive to early AD-related changes, and argued that a majority of their WM findings were explained by GM atrophy. Delano-Wood and colleagues demonstrated that decreased WM integrity of the posterior cingulum persisted after controlling for hippocampal volume or whole-brain volume. Using methods similar to the present study, Selnes and colleagues demonstrated multiple regions with decreased WM integrity in MCI, the majority of which remained significant after controlling for local cortical thickness. The current study will determine whether WM changes persist after controlling for widespread cortical thinning in regions empirically validated as particularly sensitive to the AD disease process. Demonstrating unique effects of WM integrity in MCI, independent from ADsignature cortical thinning, would add to the growing support for an independent contribution of WM integrity to AD by demonstrating this effect in an at-risk MCI sample.
Similarly, preliminary evidence suggests that the relationship between WM integrity and cognition is independent of GM changes (Bosch et al., 2012; Delano-Wood et al., 2012; Grambaite et al., 2011) , although most studies investigating the relationship between cognition and WM integrity have not controlled for GM. Studies investigating specific cognitive domains have provided initial evidence that decreased WM integrity correlates with memory (Bosch et al., 2012; Goldstein et al., 2009; Walhovd et al., 2009 ) and executive functioning in MCI Grambaite et al., 2011) . WM integrity within posterior brain regions, most notably the posterior cingulate, is also related to memory (Delano-Wood et al., 2012; Fellgiebel et al., 2005; Rose et al., 2006; Walhovd et al., 2009 ). The importance of parietal WM to executive functioning in MCI has also been suggested Jacobs et al., 2012; Kim et al., 2011) . Because multiple studies show strong relationships between cortical thickness and cognition (Chang et al., 2010; Fjell et al., 2008; Walhovd et al., 2009) , it is important to determine whether relationships between cognition and WM integrity are independent of cortical thinning.
The current study applied retrospective, neuropsychologically based MCI criteria to a sample of normally aging older adults using the ''comprehensive'' criteria described by to examine morphometric group differences in GM and WM integrity. The primary aim of this study was to examine whether decreased WM integrity in MCI would persist when controlling for AD-signature cortical thickness. A secondary aim was to determine whether WM integrity contributes to variance in cognitive performance over and above that explained by AD-signature cortical thickness. We hypothesized that, relative to a normal control (NC) group, participants with neuropsychologically defined MCI would exhibit decreased: (1) hippocampal volume, (2) AD-signature cortical thickness, and (3) WM integrity (i.e., lower fractional anisotropy) in a priori selected regions of interest (ROIs), particularly within medial temporal and parietal regions. Importantly, we predicted that differences in WM integrity across groups would be independent of cortical thinning. We also hypothesized that WM integrity of the medial temporal and parietal regions would be significantly related to poorer memory performance, and that WM integrity in parietal regions would be significantly related to poorer executive functioning, over and above AD-signature cortical thinning.
METHOD Participants
One hundred thirteen participants underwent neuropsychological testing and structural MRI. Participants were recruited 
MCI Criteria
We applied the ''comprehensive'' criteria ) for retrospective diagnosis of MCI based on neuropsychological test scores. This required that at least two performances within a cognitive domain fell one standard deviation (SD) or more below normative expectations for that domain to contribute to MCI classification. A cutoff for impairment of 1 SD below normative data was adopted to strike a balance between reliability and sensitivity to detect mild impairment (Heaton, Miller, Taylor, & Grant, 2004; 
APOE e4 Genotyping
Genomic DNA was prepared directly from peripheral blood samples using the Pure Gene (Gentra Systems, Minneapolis, MN) DNA extraction kit, with minor modifications. The DNA was stored and an aliquot removed for APOE genotyping. PCR analysis was carried out essentially as described by Wenham, Price, & Blandell (1991) .
Neuropsychological Measures
All participants completed a neuropsychological battery assessing cognitive functioning in four domains: memory, attention/processing speed, language, and executive functions. (2004) *Participants from the OAIC sample completed Logical Memory but did not complete Visual Reproduction (both were completed in the UCARE sample). Performance on Visual Reproduction has been shown to be more sensitive than Logical Memory for prediction of stable memory deficits in MCI (Teng et al., 2009) and to predict subsequent AD (Albert et al., 2001; Griffith et al., 2006; Salmon et al., 2002) . Therefore we used Visual Reproduction whenever available for group classification, and substituted Logical Memory when it was unavailable (n 5 29 Publically available standard scores were used for group classification (see Table 1 ). Although the full range of neuropsychological information was necessary for determining MCI diagnosis through use of standard scores, after group classification was completed all analyses used raw scores. Only measures of memory and executive functioning were considered when examining relationships with morphometric measures. Self-report measures included the Geriatric Depression Scale (GDS; Yesavage et al., 1982) and the Lawton and Brody instrumental activities of daily living (IADL) questionnaire (Lawton & Brody, 1969) .
Mean Arterial Blood Pressure
Blood pressure (BP) was measured in a seated position with the arm at rest at heart level by a laboratory technician using a standard sphygmomanometer after five minutes of rest, and five minutes later. Average systolic and diastolic pressures were computed across the two measurements. Systolic and diastolic blood pressure were considered together to create a mean arterial blood pressure (MABP) using the following formula:
MABP is a metric commonly used in clinical settings to obtain an accurate metric of overall blood pressure. MABP is believed to indicate perfusion pressure, particularly in body organs, and therefore may be more directly related to brain structure. In addition, prior studies have found significant relationships between MABP and cognition and brain structure in older adults (Brown et al., 2008; Guo et al., 2009; . We controlled for this variable in all analyses.
Neuroimaging Protocol
Two participants were scanned using a Siemens 1.5 Tesla Sonata system, with the following parameters: MPRAGE; T1 5 1000 ms, repetition time (TR) 5 2.73 s, echo time (TE) 5 3.39 ms, flip angle 5 78, slice thickness 5 1.33 mm, 128 slices, field of view (FOV) 5 256 3 256 mm; DTI: TR 5 9000 ms, TE 5 68 ms, 60 slices total, acquisition matrix 5 128 3 128 (FOV 5 256 3 256 mm), slice thickness 5 2 mm (for 2 mm 3 isotropic voxels) with 0 mm gap, with a b value 5 700 s/mm 2 , 10 T2 and 60 diffusion weighted images, and one image, the T2-weighted ''low b'' image with a b-value 5 0 s/mm 2 as an anatomical reference volume. The remaining 111 participants were scanned on the upgraded Siemens 1.5 Avanto System, with slightly different parameters; MPRAGE: T1 5 1000 ms, TR 5 2.73 s, TE 5 3.31 ms, flip angle 5 78, slice thickness 5 1.3 mm, 128 slices, FOV 5 256 3 256 mm; DTI: TR 5 7200 ms, TE 5 77 ms, 60 slices total, acquisition matrix 5 128 3 128 (FOV 5 256 3 256 mm), slice thickness 5 2 mm (for 2 mm 3 isotropic voxels) with 0 mm gap, with a b value 5 700 s/mm 2 , 10 T2 and 60 diffusion weighted images, and one image, the T2-weighted ''low b'' image with a b-value 5 0 s/mm 2 as an anatomical reference volume.
Image Processing

T1 image processing
Cortical thickness measurements were obtained by first conducting cortical reconstruction using the FreeSurfer image analysis suite, which is freely available for download online (http://surfer.nmr.mgh.harvard.edu/). Methods have been previously described in detail ); see our previous work for a summary of this process . Dickerson et al. (2009) used an exploratory map of cortical thinning in mild AD to define a priori ROIs for use in other analyses, termed ''AD-signature'' cortical thickness. We applied the AD-signature cortical thickness map to our subjects and derived a mean AD-signature cortical thickness value. We used average AD-signature cortical thickness because Bakkour and colleagues (2009) previously demonstrated that this measure best predicted conversion from questionable AD dementia to mild AD dementia relative to hippocampal volume and the MTL thickness ROI.
DTI image processing
Diffusion data were processed using a multistep procedure involving the FreeSurfer image analysis suite and FSL (http:// www.fmrib.ox.ac.uk.fsl/) processing streams, specifically Dtifit from FMRIB's Diffusion Toolbox (Behrens et al., 2003) and TBSS (Tract-Based Spatial Statistics, Smith et al., 2006) , part of FSL (Smith et al., 2004) . See our previous work Salat et al., 2010) for additional details.
ROIs limited to the TBSS skeleton were created using T1-based WM parcellations automatically created during the FreeSurfer processing stream ). These regional measures were based on gyral folding patterns (Desikan et al., 2006) , which were subsequently diffused from the cortex into the subjacent WM, resulting in a WM parcellation for each gyral label, unique to each individual's anatomy (see Salat et al., 2012) . Registration of the T1 image to the low b volume was performed using the FreeSurfer bbregister tool ), a procedure that uses tissue contrast (gray/white matter) as the basis of the registration cost function. Use of the FreeSurfer derived segmentations provided definition of WM regions directly beneath the cortex (Fischl et al., 2002; Salat et al., 2009) . ROIs were selected to include those within medial temporal and parietal regions known to be affected early in the AD process, with additional preference given to WM regions underlying those regions that contributed to the AD-signature cortical thickness ROIs . ROIs included WM underlying the following cortical regions: entorhinal, parahippocampal (combined for some analyses into average medial temporal); posterior cingulate, precuneus, supramarginal, superior parietal (combined for some analyses into average parietal); transverse temporal, superior temporal, 
Statistical Analyses
Group comparisons were performed with analysis of covariance (ANCOVA) to test for differences (NC vs. MCI) in morphometric variables, controlling for age, education, and MABP. In addition, similar ANCOVAs were performed for morphometric variables showing significant group differences, also controlling for AD-signature cortical thickness. To examine the relationship between ROIs and cognition, factor scores were created to reduce the number of neuropsychological variables. Raw scores for each variable contributing to the Memory and Executive domains for the MCI classification criteria were submitted into a principal components analysis using varimax rotation with two fixed factors; the minimum eigenvalue for extraction was set at 1. The two factors explained a total of 65% of the variance. The first factor extracted was called ''Memory,'' and explained 50% of the variance. Because California Verbal Learning Test -Second Edition (CVLT-II) variables showed comparable loadings on both factors, they were assigned to the Memory factor based on our conceptual understanding of these measures (see Table 2 ). The second factor was called ''Executive,'' explaining 15% of the variance. The demonstrated factor solution corresponded with the domains used for MCI classification. Factor scores were saved. Hierarchical multiple regressions were completed to determine the relative contribution of WM integrity and AD-signature cortical thickness to the Memory and Executive factors scores. Age, education, and MABP were entered into the first step, AD-signature cortical-thickness was entered into the second step, and WM integrity was entered in the third step. Six hierarchical regressions were run in total, three for each cognitive factor score, with average FA, medial temporal FA, and parietal FA entered in the last step of each model. A significance level of p , .05 was used for all analyses and effect sizes (partial eta squared) are reported for all primary analyses. All analyses were conducted in SPSS (Version 19.0).
RESULTS
The MCI and NC groups were comparable on age (t 5 20.39; p 5 .70), education (t 5 20.29; p 5 .77), sex (w 2 5 0.13; p 5 .72), MABP (t 5 1.54; p 5 .13), GDS (t 5 21.06; p 5 .29), Lawton and Brody IADL score (t 5 1.68; p 5 .10), and MMSE (t 5 1.61; p 5 .11). There was a greater proportion of African Americans in the MCI group, although this difference only approached significance (w 2 5 4.16; p 5 .05). Due to targeted recruitment, a large percentage (88%) had a self-reported positive family history of AD, and this percentage was comparable across MCI and NC groups (w 2 5 0.06; p 5 .81). Twenty-six percent of the sample was apolipoprotein e4 positive. There were a higher percentage of APOE e4 positive participants in the MCI group (31.25%) than in the NC group (23.5%), although this difference was not significant (w 2 5 1.60, p 5 .21). These values exceed what has been documented in the general population (15%; Strittmatter & Roses, 1995) , which may be attributable to the greater proportion of individuals with a family history of AD (see Table 3 ). See Table 4 for performance on neuropsychological measures across groups. Table 5 and Figure 1 ).
Group Comparisons
Group Comparisons Controlling for AD-Signature Cortical Thickness
Group comparisons controlling for age, education, MABP, and AD-signature cortical thickness Figure 1) . Table 6 ).
Association of Morphometric and Neuropsychological Variables
DISCUSSION
In this sample of healthy older adults with a high rate of family history of Alzheimer's disease, an MCI group characterized using comprehensive neuropsychological criteria ) exhibited decreased hippocampal volume and WM integrity relative to normal controls. Nearly all differences in WM integrity were statistically independent of AD-signature cortical thinning. Furthermore, WM integrity was related to cognition, independent of cortical thinning. Consistent with our hypotheses, the current results demonstrated decreased hippocampal volume in the MCI group. Despite the well-known finding of hippocampal volume loss in MCI (Shi, Liu, Zhou, Yu, & Jiang, 2009) , this is only the second study to demonstrate this when defining MCI through a neuropsychological approach (Jak, Bangen, et al., 2009) . We also demonstrated a trend toward widespread cortical thinning (i.e., decreased AD-signature cortical thickness) in MCI.
As hypothesized, the present study demonstrated decreased WM microstructural integrity as manifested in lower average FA (of our selected ROIs) and lower parietal FA among the MCI group. Parietal WM degeneration has been previously documented in MCI (Bosch et al., 2012; Chua, Wen, Slavin, & Sachdev, 2008; Delano-Wood et al., 2012; Medina et al., 2006; Rose et al., 2006; Scola et al., 2010; Shim, Yoon, Shon, Ahn, & Yang, 2008; Shu, Wang, Qi, Li, & He, 2011; Zhuang et al., 2010) . Within ROIs comprising our measure of posterior WM, FA in the posterior cingulate was significantly decreased. Decreased WM integrity in the posterior cingulate has emerged as a highly replicable finding across DTI studies of MCI and AD (Catheline et al., 2010; Chua et al., 2009 Chua et al., , 2008 Delano-Wood et al., 2012) . These results suggest that alterations within posterior WM regions, particularly the posterior cingulate, may serve as a potential imaging biomarker of early AD-related brain changes. The results of the present study extend the existing literature by demonstrating that parietal WM changes remained significant even when controlling for 
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AD-signature cortical thickness, suggesting that posterior WM changes are independent of grey matter atrophy within this susceptible population. The lack of decreased WM integrity in our average medial temporal WM ROI is unexpected and inconsistent with our hypotheses. Within individual ROIs, the MCI group showed decreased FA in WM underlying the entorhinal, but not parahippocampal, cortex. Other studies have identified decreased WM integrity in parahippocampal WM in MCI (Liu et al., 2011; O'Dwyer et al., 2011; Rose et al., 2006; Zhang et al., 2007) . One possible explanation for this discrepancy is that our sample may represent early MCI, as these are individuals who were neurologically normal per history, identified only by neuropsychological status. Another possible explanation for the lack of parahippocampal WM differences in our study may be due to collapsing across aMCI and naMCI groups. Zhuang and colleagues (2010) demonstrated a differing pattern of results in a large sample of aMCI, naMCI, and healthy control subjects; although widespread differences relative to control subjects were found in both MCI groups, significant differences in temporal WM were only found in the aMCI group. Of note, however, is that they found no significant differences when directly comparing aMCI and naMCI groups. Our results are consistent with Grambaite and colleagues (2011) ; their investigation also demonstrated decreased integrity in the WM underlying the entorhinal, but not parahippocampal, cortex in aMCI relative to a ''lessadvanced'' MCI sample. AD neuropathology is present in the entorhinal cortex in the earliest stages of the disease process, even before the hippocampus and parahippocampal gyrus (Braak & Braak, 1996; Gomez-Isla et al., 1996) , and a similar pattern of findings has been documented in morphometry studies focused on GM alterations (Desikan et al., 2009; Devanand et al., 2012; Fennema-Notestine et al., 2009) . Similarly, the more anterior (entorhinal) findings would be expected given that in AD the degenerative changes in the parahippocampal WM seem to follow an anterior to posterior gradient . WM underlying the entorhinal cortex has not been frequently included as an ROI in past DTI studies. Our methodological approach that applies T1-based cortical parcellations to the underlying WM facilitated inclusion of this ROI. Potential advantages of this method include correspondence between WM and cortical thickness ROIs and a clearly defined method by which to replicate analyses. Given our finding of decreased WM integrity in the WM underlying the entorhinal cortex in this mixed aMCI and naMCI sample, which persisted even when controlling for AD-signature cortical thickness, this region deserves further investigation in future MCI studies.
The current results provide support for the relative independence of decreased WM integrity in MCI from GM atrophy as measured by widespread cortical thinning in regions known to be sensitive to AD. These results are consistent with those of Selnes et al. (2012) who also demonstrated that most of the MCI group differences in WM integrity persisted despite controlling for localized cortical thinning. Collectively, our findings also suggest that changes in WM integrity explain unique variance and may precede, or Leszek, Sochocka, & Gasiorowski, 2012) . Vascular risk factors are easily modifiable, thus, could possibly prevent development of dementia later in life through early preventative efforts or could potentially slow cognitive decline (Richard & Pasquier, 2012) . Further determining white matter's contribution to early detection by regularly including DTI in conversion studies and in clinical trials may significantly impact future treatment and prevention efforts. Analyses investigating associations with cognition highlighted that the clinical significance of WM changes may also be independent from gray matter changes. Overall, these results show that across a sample of healthy older adults and individuals with MCI, WM integrity explains variance in cognition over and above cortical thickness in regions shown to be sensitive to early AD-related changes. Analyses within specific cognitive domains partially supported our hypotheses. As predicted, medial temporal FA was significantly related to memory performance. Furthermore, consistent with results of Grambaite and colleagues (2011) , we demonstrated that this relationship was independent of cortical thinning. Unlike their study wherein they locally controlled for cortical thinning, we demonstrate that this relationship persists when accounting for widespread cortical thickness in a pattern known to be sensitive to early AD neuropathological changes (Dickerson et al., 2011) . Also consistent with Grambaite and colleagues, we did not find a relationship between parietal WM integrity and memory performance. Other studies have demonstrated a relationship between parietal WM regions such as the posterior cingulate (Fellgiebel et al., 2005; Rose et al., 2006) , but these studies did not control for gray matter changes. Results also revealed a relationship between parietal WM integrity and executive functioning, consistent with findings from other investigators Jacobs et al., 2012; Kim et al., 2011) . The current results extend prior findings by demonstrating that this relationship is independent of cortical thinning. Additional work applying a voxelwise approach is needed to more extensively examine which WM regions correlate with memory and executive functioning.
This study has several limitations. Investigation of the relationship between WM and cognition collapsed across groups to avoid arbitrarily restricting range and to maximize power. Furthermore, because the same measures used for the Memory and Executive domains in MCI diagnosis were used for the Memory and Executive Factors for these analyses, inclusion of group status in the regression model or limiting analyses to subgroups may be viewed as partially dependent. Therefore, results from our regression analyses must be interpreted with caution, as results suggest that there is a relationship between these cognitive domains and FA, supporting potential clinical implications of variation in white matter integrity over and above cortical thinning, but do not suggest specificity of these relationships to MCI. Because a subjective or objective change in cognition over time was not required for MCI diagnosis in the current study, and follow-up data is not available, it remains possible that the current results could reflect normal variability in morphology that is also related to cognitive strengths and weaknesses, rather than an early Alzheimer's process. The elevated prevalence of family history and APOE e4 rates offer some argument against this, but future work is needed with prospectively diagnosed MCI to selectively include MCI presumed to be due to AD . Longitudinal studies are needed to examine the relative ability of WM integrity versus measures of GM to predict conversion from MCI to Alzheimer's dementia and to replicate the current results in a sample destined to develop AD. The current sample, while at risk for AD, may reflect a variety of etiologies for MCI. While the elevated rate of family history of AD and the APOE e4 allele relative to the general population increases the likelihood of preclinical AD within this sample, it may limit the generalizability of our results. In addition, the difference in rate of MCI in African American and Caucasian participants approached significance. Although we used normative data with corrections for ethnicity whenever possible (Heaton et al., 2004) , not all measures included in this study had this option. Our group is currently working on a separate manuscript to examine potential differences across our African American and Caucasian participants. Due to small sample sizes and an effort to limit the number of analyses, we chose not to analyze aMCI and naMCI subgroups separately given evidence that naMCI frequently represents early AD (Fischer et al., 2007; Rountree et al., 2007; Schneider, Arvanitakis, Leurgans, & Bennett, 2009 ). However, this may have affected our ability to detect medial temporal lobe effects (Zhuang et al., 2010) . Ongoing studies will expand our MCI sample, allowing for us to more specifically investigate morphometric differences in amnestic and non-amnestic MCI.
In summary, we found evidence that neuropsychologically defined MCI is associated with reduced gray and white matter integrity, and group differences in WM integrity persisted even when controlling for cortical thickness in regions WM integrity MCI 933 sensitive to the AD process. This is the first study to demonstrate that decreased integrity in entorhinal and parietal WM in MCI may be independent of widespread gray matter changes. Moreover, results suggest that changes in WM integrity are clinically significant and cannot be fully attributed to gray matter atrophy. Future work will explore whether similar results can be demonstrated in prospectively diagnosed MCI and further examination of potential differences by MCI subtype is needed. Improved understanding of the pattern of WM changes that develop in early AD and prodromal AD states such as MCI has important implications for early detection and monitoring treatment effects in clinical trials, and the current study suggests a prominent and preferential role of parietal and temporal lobe WM integrity and relationships to cognition during this critical stage.
